Compliance & Validation — Not documented by Atlas
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
AI-enabled pharmacovigilance product suite spanning case intake, literature monitoring, signal detection, and PV analytics.
PV Analytica, founded in 2024 with offices in East Windsor, New Jersey and Gurgaon, India, offers a suite of AI-enabled pharmacovigilance products covering intake automation, literature monitoring, signal detection, reconciliation, and AI governance. The founding team cites prior experience delivering PV technology programs at large pharmaceutical companies, but the company itself is young and bootstrapped: no public funding, third-party certifications, or named production customers were identified at profiling time. Treat it as an emerging vendor — a structured pilot with clear acceptance criteria is the sensible entry point.
50% — Partial coverage. Coverage score — how completely Atlas documents PV Analytica across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
cloud
Ask the vendor: What is your pricing model, and what drives total cost of ownership?
Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?
Biotech Startup, Mid-Size Biotech, Pharmacovigilance
Adverse Event Detection
Private, Founded 2024
Not captured in Atlas data — confirm directly. Excluded from the score above.
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?